-+ 0.00%
-+ 0.00%
-+ 0.00%

VISTAGEN THERAPEUTICS INC - FDA LETTER ENABLES FURTHER PHASE 2 DEVELOPMENT OF REFISOLONE IN THE U.S.

Reuters·04/22/2026 12:30:01

Please log in to view news